7P13SR- TWO- SHEET1

profileSa1_Jyyy
IllustrativeexampleforpreparingChapter5forMN7P13SRAS1.pdf

Note: Text in RED are explanatory notes or inserts, and are NOT to be included together with

your text when preparing your actual assignment

Illustrative example for preparing Chapter 5 for MN7P13SR AS1

(The following example is based on the project described in ”AS3 Assessment Walkthrough.pdf”

and follows on from “Example format for Workplan (for MN7P13SR AS1).pdf”)

NOTE: Briefly, this chapter requires students to analyse the available evidence (i.e. from

literature specifically about particular issues related to the solutions within the target

organisation) and describe/explain:

1. The reason or reasons for why each of the solutions (from the High Impact – High Controllability quadrant) had not been implemented yet (i.e. why the organisation did not implement the solutions even though these solutions have high impact and are highly controllable by the company) (If there are available relevant visual aids to support your arguments (e.g., graphs, infographics), you should include these to support your description/explanation) AND

2. What further action or actions the organisation need to take to implement each of these solutions

Chapter 5 – Analysis and Findings

Situation

Observation (i.e. of complications that prevents the organisation from achieving objectives)

Implication (this is summary of measures to be taken to resolve the situation, i.e. resolution

to the problem)

Example:

Situation: Techpioneer is an industry leader in the area of AI diagnostic tools and seeks to

launch a groundbreaking AI tool …

Observation: However, the introduction of this tool has been hampered by regulatory

requirements that Techpioneer has no prior experience in meeting and …

Implication: To meet regulatory requirements, Techpioneer therefore needs to …

(The above should be kept brief, i.e. 1 or 2 sentences each, because similar information would

be displayed in the content for following worksheet/chapter)

Note: Text in RED are explanatory notes or inserts, and are NOT to be included together with

your text when preparing your actual assignment

Example:

Research Question 1: What needs to be done to enhance the current AI tool to be able to meet

regulatory requirements?

In this industry, the regulator (FDA) has specified strict regulatory requirements for all relevant tools

in order to ensure the safety of the public (Source, e.g. “Regulatory standards documentation and

compliance guidelines issued by … ministry/agency/department” *). The AI tool that Techpioneer

intends to market must therefore meet relevant regulatory requirements before it can be launched.

Based on the gap analysis* undertaken of the requirements and the quality of the AI tool, the current

version of AI tool that Technpioneer plans to introduce does not fully meet the regulatory

requirements yet.

Our current hypothesis is that the company currently has the ability to design the AI tool to meet

regulatory requirements (Source, e.g. “Company’s current AI tool’s specifications” *), but has not

committed the required resources to do so because it had other more urgent priorities to attend to

that took up all the available relevant resources that could have been used to design the AI tool to

meet regulatory requirements.

When analysing the company’s projects in the relevant period (i.e. 2022 to 2024), it was found that

the company was also involved in another major project, i.e. Project A, during the relevant time period

that had overrun its original deadline due to unforeseen technical difficulties. This required much of

the company’s in-house AI design personnel to work on Project A (Source). A comparative analysis *

of the costs involved and the expected financial consequences (or this could also be regarded as a cost-

benefit analysis *) revealed that If it did not deliver this project within a revised deadline, the company

would have faced major legal issues and substantial financial penalties for delays in the completion of

the project (Source).

As such, Techpioneer chose to devote its resources to complete Project A instead of fully revising the

AI tool to meet regulatory requirements. This resulted in the AI tool that the company planned to

introduce not being able meet the regulatory requirements yet (Source).

Insight: Ultimately, the company has the ability to design the AI tool to meet regulatory requirements,

but has not committed the required resources to do so due to unforeseen circumstances that forced

it to deploy the relevant resources to another urgent project. It therefore needs to re-evaluate its

current and projected resources to revise the AI tool to meet regulatory requirements before it can

launch the tool.

Research Question 2: What does the company need to do to conduct extensive peer-reviewed clinical

trials?

In this industry, it is a regulatory requirement to conduct extensive, peer-reviewed clinical trials before

any product can be introduced into the market (Source). Techpioneer must therefore test and validate

the quality of the AI tool before it can be introduced into the market. Based on the gap analysis *

undertaken of the requirements and the absence of work done in the area by the company, it is

obvious that the Technpioneer has to conduct extensive, peer-reviewed clinical trials to meet the

regulatory requirements before it can market the AI tool.

Note: Text in RED are explanatory notes or inserts, and are NOT to be included together with

your text when preparing your actual assignment

Our current hypothesis is that the company has not done so is because it currently lacks adequate

internal resources to conduct extensive peer-reviewed clinical trials. A review of the company’s

internal policy documents * regarding the conduct extensive peer-reviewed clinical trials (Source)

reveal that the company has expertise in AI design but it has no experience in developing an AI

diagnostic tool for use in healthcare (Source).

To meet this requirement, Technpioneer would therefore need to acquire the necessary expertise in

this area. One way that it could begin the process is to consult its own industry’s or related industry’s

sources on the resources required for conducting extensive peer-reviewed clinical trials (Source). This

would be followed by a cost-benefit analysis * on the most cost-effective way to acquire the resources

to conduct extensive, peer-reviewed clinical trials. In this respect, it is expected that no matter how it

intends to proceed, the company has the financial means to conduct extensive, peer-reviewed clinical

trials based on its current financial strength (Source, e.g. financial analysis of company *)

Insight: In summary, the company currently lacks adequate internal resources to conduct extensive

peer-reviewed clinical trials to meet regulatory requirements, but is expected to be able to acquire the

ability to do so. It therefore needs to evaluate the most cost-effective way to conduct extensive peer-

reviewed clinical trials and to devote the necessary resources (i.e. money, time, etc.) before it can

launch the tool.

Research Question 3: …

* : We realise that in real consulting projects, data sources and data analysis techniques

ultimately used may differ from those originally proposed as the project progresses, so some

small amount of leeway is allowed if the data sources and data analysis techniques of the

Workplan and those in Chapter 5 do not match completely. However, as much as possible, and

where it makes sense, please try to match the data sources and data analysis techniques that

you proposed in the Workplan with those indicated in Chapter 5.

IMPORTANT: Misrepresenting/faking information is bad practice, and you will be penalised

if caught doing so. The sources used in the analysis should therefore actually provide the

information mentioned in Chapter 5.

If the required information is not available for you to include any issue and/or solution in the

assignment, It would be far better to exclude these and include only actual events and data

even if that means you need to reduce the number of issues and/or solutions ultimately

included in the report.

In this respect, please be assured that we are more concerned with the quality of the content

of the report than with simply the quantity, i.e. number of issues (in the initial logic tree) or

number of solutions (in the complete logic tree (deductive logic or hypothesis or combination)

logic tree), which ultimately affect the number of issues in the Workplan and above analysis.